Home › Alpha-1 Antitrypsin Deficiency › NCT00500123
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
RecruitingObservational studyHealthy volunteers welcome
Who can join
All ages · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Individuals of any age at risk for alpha-1 antitrypsin deficiency on the basis of symptoms or family genetic risk. Exclusion Criteria: * Any person who has already had genotype and AAT level testing completed and has a qualified result.
About the study
The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.
What is being tested
- Alpha-1 Antitrypsin Genotype (procedure)
Sponsor: University of Florida · Participants: 50,000 · Started: 2001-01
Contact the study team
- Michelle Owens, RN, BSN · Phone: 352-273-6339
- Allison Faunce, B.A. · Phone: 352-273-8666
Official record on ClinicalTrials.gov — NCT00500123
Locations in the U.S.
| Florida | University of Florida, Gainesville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.